Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04302272 · ClinicalTrials.gov registry record
STRIVE Post-Market Registry Study
A clinical trial of Emphysema, sponsored by Olympus Corporation of the Americas.
- Recruiting
- Registry status
- 150
- Enrollment target
- 13
- Study locations
NCT04302272 is a study of Emphysema that is actively recruiting participants, run by Olympus Corporation of the Americas. The registered enrollment target is 150 participants, below the 3,797-participant average among 25 other Emphysema trials with a reported enrollment target (96% lower). The trial reports 13 study locations across 10 states.
The verdict
NCT04302272, a study of Emphysema, is actively recruiting participants, sponsored by Olympus Corporation of the Americas.
- RECRUITING
- Registry status
- 150 participants
- Enrollment target
- 13
- Study locations
Study Summary
This is a single-arm, prospective, multi-center, Registry study to evaluate the long-term safety and effectiveness of the Spiration Valve System (SVS) for the treatment of severe emphysema in a post-market setting.
Conditions Studied
Interventions
- DEVICE Spiration Valve System (SVS)
Study Locations (13)
Illinois
- Northwestern University, Division of Pulmonary and Critical Care Medicine - Chicago
- University of Chicago - Chicago
Pennsylvania
- Penn State Milton S. Hershey Medical Center - Hershey
- Temple University - Philadelphia
Texas
- Baylor Scott & White Research Institute - Dallas
- University of Texas Southwestern - Dallas
Arizona
- Dignity Health St. Joseph's Hospital and Medical Center - Phoenix
California
- El Camino, Taft Center for Clinical Research - Mountain View
Louisiana
- LSU Health Shreveport - Shreveport
Massachusetts
- Beth Israel Decaconess - Boston
Mississippi
- Memorial Hospital at Gulfport - Gulfport
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2021-10-09 |
| Est. Completion | 2028-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04302272
The ClinicalTrials.gov registry entry for NCT04302272 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,797-participant average among 25 other Emphysema trials with a reported enrollment target (96% lower). The listed sponsor is Olympus Corporation of the Americas, which has 14 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Emphysema appearing as the primary indexed condition, and to 1 intervention - of which Spiration Valve System (SVS) is the first listed.
NCT04302272 reports 13 study locations spanning 10 distinct geographic areas - top geographies include Illinois, Pennsylvania, Texas.
Frequently Asked Questions
What is clinical trial NCT04302272 about?
NCT04302272 is a clinical study titled "STRIVE Post-Market Registry Study". This is a single-arm, prospective, multi-center, Registry study to evaluate the long-term safety and effectiveness of the Spiration Valve System (SVS) for the treatment of severe emphysema in a post-market setting.
What is the current status of trial NCT04302272?
This trial is currently recruiting. The enrollment target is 150 participants. The study started on 2021-10-09. Estimated completion is 2028-04.
What conditions does trial NCT04302272 study?
This clinical trial studies the following conditions: Emphysema.
What interventions are being tested in trial NCT04302272?
The interventions under investigation include: Spiration Valve System (SVS) (DEVICE).
Who is sponsoring clinical trial NCT04302272?
This trial is sponsored by Olympus Corporation of the Americas, which has 14 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04302272 being conducted?
This trial has 13 study locations across Arizona, California, Illinois, Louisiana, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Emphysema
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
COPD Patient-Powered Research Network
RECRUITING
-
Site and Mechanism(s) of Expiratory Airflow Limitation in COPD, Emphysema and Asthma-COPD Overlap
RECRUITING
-
Long-term, Open-label Study of SAR447537 (INBRX-101) in Adults With Alpha-1 Antitrypsin Deficiency Emphysema
RECRUITING · Phase 2
-
Biological Effects of Quercetin in COPD Phase II
RECRUITING · Phase 2
-
Bronchoscopic RElease of Air Trapped in Hyperinflated Emphysematous Lung - Study 3
RECRUITING · NA
-
Implementation of a Sarcopenia Clinic to Diagnose and Treat Skeletal Muscle Loss Due to COPD
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.